Matthias Willmann
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 22
-
- Gut microbiota and health 7
- Genomics and Phylogenetic Studies 5
- Co-authors
- Silke Peter (30 shared papers)Matthias Marschal (14 shared papers)Ingo B. Autenrieth (18 shared papers)Christopher Weidenmaier (4 shared papers)Daniela Janek (1 shared paper)Christoph Slavetinsky (1 shared paper)Bernhard Krismer (1 shared paper)Nadine A. Schilling (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (6 papers)Frontiers in Microbiology (3 papers)Journal of Antimicrobial Chemotherapy (3 papers)BMC Infectious Diseases (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- GermanySpainSwitzerland
In The Last Decade
Matthias Willmann
40 papers receiving 1.8k citations
Matthias Willmann's Hit Papers
Peers
Comparison fields: 5 of 121
- Molecular Medicine 503
- Applied Microbiology and Biotechnology 109
- Clinical Biochemistry 254
- Endocrinology 140
- Microbiology 156
Countries citing papers authored by Matthias Willmann
This map shows the geographic impact of Matthias Willmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Willmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Willmann more than expected).
Fields of papers citing papers by Matthias Willmann
This network shows the impact of papers produced by Matthias Willmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Willmann. The network helps show where Matthias Willmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthias Willmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human commensals producing a novel antibiotic impair pathogen colonization Hit paper breakdown → | 2016 | 669 |
| 2 | 2017 | 136 | |
| 3 | 2019 | 109 | |
| 4 | 2015 | 73 | |
| 5 | 2020 | 66 | |
| 6 | 2017 | 62 | |
| 7 | 2017 | 51 | |
| 8 | 2012 | 50 | |
| 9 | 2015 | 49 | |
| 10 | 2015 | 48 | |
| 11 | 2014 | 42 | |
| 12 | 2019 | 36 | |
| 13 | 2019 | 34 | |
| 14 | 2013 | 28 | |
| 15 | 2019 | 28 | |
| 16 | 2022 | 24 | |
| 17 | 2013 | 22 | |
| 18 | 2013 | 19 | |
| 19 | 2014 | 19 | |
| 20 | 2018 | 18 |
About Matthias Willmann
Matthias Willmann is a scholar working on Molecular Medicine, Molecular Biology, Clinical Biochemistry, Endocrinology and Infectious Diseases, having authored 41 papers that have together received 1.8k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (22 papers), Bacterial Identification and Susceptibility Testing (8 papers), Gut microbiota and health (7 papers), Genomics and Phylogenetic Studies (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Infections and bacterial resistance (3 papers) and Antibiotic Use and Resistance (3 papers). The work is most often cited by research in Molecular Medicine (503 citations), Applied Microbiology and Biotechnology (109 citations), Clinical Biochemistry (254 citations), Endocrinology (140 citations) and Microbiology (156 citations). Matthias Willmann has collaborated with scholars based in Germany, Spain and Switzerland. Frequent co-authors include Silke Peter, Matthias Marschal, Ingo B. Autenrieth, Christopher Weidenmaier, Daniela Janek, Christoph Slavetinsky, Bernhard Krismer, Nadine A. Schilling, Stephanie Grond and Martin C. Konnerth. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Frontiers in Microbiology, Journal of Antimicrobial Chemotherapy, BMC Infectious Diseases and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.